End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.98 CNY | +2.46% | +1.08% | +2.32% |
2023 | Cisen Pharmaceutical Scraps Unit Spin-Off Plan | CI |
2023 | Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2021 | 3.78B 523M | Sales 2022 | 4.07B 562M | Capitalization | 5.67B 783M |
---|---|---|---|---|---|
Net income 2021 | 334M 46.16M | Net income 2022 | 350M 48.37M | EV / Sales 2021 | 0.98 x |
Net cash position 2021 | 2.28B 315M | Net cash position 2022 | 2.63B 363M | EV / Sales 2022 | 0.75 x |
P/E ratio 2021 |
18
x | P/E ratio 2022 |
16.4
x | Employees | 3,413 |
Yield 2021 |
2.25% | Yield 2022 |
2.66% | Free-Float | 37.54% |
1 day | +2.46% | ||
1 week | +1.08% | ||
Current month | +4.32% | ||
1 month | +4.32% | ||
3 months | -3.97% | ||
6 months | +12.21% | ||
Current year | +2.32% |
Managers | Title | Age | Since |
---|---|---|---|
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
En Long Zhao
CHM | Chairman | 45 | 04-06-30 |
Xiang Liu
BRD | Director/Board Member | 35 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
BRD | Director/Board Member | 59 | 17-11-27 |
Zhen Xin Du
CEO | Chief Executive Officer | 57 | 98-11-05 |
Xin Sheng Sun
BRD | Director/Board Member | 71 | 17-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 14.98 | +2.46% | 3,870,760 |
24-04-16 | 14.62 | -3.31% | 4,434,775 |
24-04-15 | 15.12 | -0.46% | 3,204,208 |
24-04-12 | 15.19 | -0.52% | 3,062,652 |
24-04-11 | 15.27 | +3.04% | 4,062,500 |
End-of-day quote Shanghai S.E., April 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+2.32% | 933M | |
+21.93% | 44.1B | |
+17.91% | 21.97B | |
+10.48% | 13.27B | |
+3.70% | 13.22B | |
+37.38% | 11.36B | |
-8.25% | 7.07B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.09% | 5.23B |
- Stock Market
- Equities
- 603367 Stock